Survey on the Clinical Assessment of the Psychological Status of a Patient Over 75 Years Old in Oncology During the Realization of the G8 Score (CADEPO)

Survey on the Clinical Assessment of the Psychological Status of a Patient Over 75 Years Old in Oncology During the Realization of the G8 Score

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05681793

Acronym

CADEPO

Enrollment

200

Registered

2023-01-12

Start date

2023-01-17

Completion date

2023-04-02

Last updated

2023-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Brief summary

The goal of this observational study is to make a statement concerning the identification of depressive symptoms at the time of the realization of the G8 score in patients over 75 with cancer and followed in oncology. The main question it aims to answer are: * Compare the medical hetero-evaluation of depressive symptoms via the G8 neuro-psychiatric disorders item score with a self-evaluation via the GDS-15 score * Evaluate the number of patients over 75 treated with antidepressants * Evaluate the proportion of patients with depressive symptoms according to the predisposing factors * Compare the number of patients followed in oncogeriatrics over the period from 01/01/2022 to 02/28/2022 and the period from 01/01/2023 to 02/28/2023 Participants will complete a self-questionnaire (GDS-15 score) as well as a socio-demographic sheet.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

75 Years to 95 Years

Healthy volunteers

Inclusion criteria

* Patients aged 75 and over * Patients receiving treatment at the day hospital or oncology week hospital * Patients informed and having not presented any opposition to their participation

Exclusion criteria

* Patients under the age of 75 * Patients under guardianship or curatorship * Patients without social security * Cognitive disorders compromising the understanding of the information and the performance of the study (in particular the completion of a self-administered questionnaire), in the opinion of the oncologist

Design outcomes

Primary

Measure	Time frame	Description
Comparison the medical hetero-evaluation of depressive symptoms via the G8 neuro-psychiatric disorders item score with a self-evaluation via the GDS-15 score, in patients over 75 years of age with cancer and follow-up in oncology	2 months	Difference between the evaluation of the health professionals of the item Neuropsychiatric problems of the G8 score (no depression versus moderate or severe depression) and the responses of the patients to the self-administered questionnaire GDS-15 (Geriatric Depression Scale) ( 0 to 4: normal versus 5 to 15: moderate to severe depression).

Secondary

Measure	Time frame	Description
Evaluation of the number of patients over 75 on antidepressants included in this study	2 months	Percentage of patients included in this study and being treated with antidepressants
Evaluation of the proportion of patients with depressive symptoms according to the predisposing factors with a sociodemographic sheet and from the medical file	2 months	Percentage of patients with depressive symptoms according to the predisposing factors (age, gender, housing in urban or rural areas,distance (in travel time) between the oncology department and home, social isolation, income, marital status, socio-professional category, type of cancer), taken from a sociodemographic sheet distributed to the patient and from the medical file
Compare the number of patients followed in oncogeriatrics over the period from 01/01/22 to 02/28/22 and the period from 01/01/2023 to 02/28/2023	2 months	Percentage of patients followed in oncogeriatrics over the period from 01/01/2022 to 02/28/2022 and the period from 01/01/2023 to 02/28/2023

Countries

France

Outcome results